Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2014-04-30
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep Apnea in Lung Cancer: A Prospective Study
NCT02764866
Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
NCT02648087
Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung Cancer
NCT06495346
Sleep Disturbance in Lung Cancer Patients.
NCT00187980
OSA in Never Smokers With Lung Cancer
NCT05224180
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
sleep apnea screening with ApneaLinkTM
This is the only group in the present study. Patients with bronchial carcinoma (or reasonable suspicion) perform sleep screening with ApneaLinkTM at home or during the hospitalization.
sleep apnea screening with ApneaLinkTM
ApneaLink is sleep-screening tool that objectively identifies patients with sleep apnea
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sleep apnea screening with ApneaLinkTM
ApneaLink is sleep-screening tool that objectively identifies patients with sleep apnea
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with sleep apnea who had recently been diagnosed with bronchial carcinoma.
Exclusion Criteria
* other already known malignancies or tumors
* Patients with non-invasive artificial respiration due to a chronic respiratory insufficiencies
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RWTH Aachen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Dreher, Univ.-Prof.
Role: PRINCIPAL_INVESTIGATOR
RWTH Aachen University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medizinische Klinik I Uniklinik RWTH Aachen
Aachen, North Rhine-Westphalia, Germany
Krankenhaus Merheim
Cologne, North Rhine-Westphalia, Germany
Florence-Nightingale Hospital
Düsseldorf, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Michael Dreher, Univ.-Prof.
Role: primary
Tobias Müller, PD Dr. med.
Role: backup
Hendrik Storre, PD.Dr.
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Dreher M, Kruger S, Schulze-Olden S, Keszei A, Storre JH, Woehrle H, Arzt M, Muller T. Sleep-disordered breathing in patients with newly diagnosed lung cancer. BMC Pulm Med. 2018 May 16;18(1):72. doi: 10.1186/s12890-018-0645-1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-136
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.